Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

CLDN18.2 in colorectal mucinous adenocarcinoma: a lineage-associated biomarker and emerging translational target

Current evidence supports CLDN18.2 as a candidate biomarker for biomarker-enriched investigation, not as an established therapeutic target in CMA, and proposes a framework centered on lineage reprogramming, antigen enrichment, assay standardization, and therapeutic translation.

Wei Yu, Sheng-Tian Wei, Shi-Qing Wan et al. · 0 citations
Case report Open access Sep 2026

Concurrent EGFR exon 19 deletion-insertion and germline BRCA1 alteration in KRAS-wild-type pancreatic ductal adenocarcinoma: A case report and review of therapeutic implications

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid malignancies, with a dismal prognosis and a 5-year overall survival rate of 5–10%. Owing to the absence of specific symptoms at early stages, the majority of patients are first diagnosed with already locally advanced or metastatic disease. Cons...

Sheng-Tian Wei, Wei Yu, Qiao Huang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.